Please login to the form below

Not currently logged in


This page shows the latest rheumatology news and features for those working in and with pharma, biotech and healthcare.

GSK pushes rheumatoid arthritis antibody into phase 3

GSK pushes rheumatoid arthritis antibody into phase 3

It has taken the decision to push otilimab into phase 3 on the strength of the mid-stage BAROQUE trial, which was reported at the American College of Rheumatology (ACR) congress

Latest news

More from news
Approximately 1 fully matching, plus 72 partially matching documents found.

Latest Intelligence

  • NHS regional footprints NHS regional footprints

    For example, the CCG has contracted services for musculoskeletal disorders (MSK), from the Nottinghamshire Integrated Care Partnership (ICP), which is now delivering services around rheumatology, arthritis, physiotherapy, imaging, primary care

  • Case study: Immunology education Case study: Immunology education

    There are immunological links between immune-mediated inflammatory diseases (IMIDs) in dermatology, gastroenterology and rheumatology, with patients often presenting with multiple conditions. ... Setting up a virtual biologics clinic (Manchester Royal

  • Pharma deals during April 2014 Pharma deals during April 2014

    proteinuria associated with nephrotic syndrome, certain rheumatology-related conditions, and infantile spasms. Whilst this is a 60-year old drug acquired by Questcor in 2001 for $100, 000, generic competition is

  • Pharma deals during February 2014 Pharma deals during February 2014

    in litigation over two synthetic versions of Acthar (ACTH), a corticotropin with 19 indications, many in rare diseases including infantile spasms, MS, nephrology, and rheumatology.

  • Interview: Pierre Chancel, Sanofi Diabetes Interview: Pierre Chancel, Sanofi Diabetes

    Marketing Director Theraplix,  Rhône-Poulenc. Business Unit Manager for CNS, Rheumatology and HRT, Rhône-Poulenc.

More from intelligence
Approximately 0 fully matching, plus 10 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest from PMHub

  • Lucid Group welcomes new magical talent and boosts their medical writing teams with hires in the US and UK

    Hazel Urwin joins Lucid Partners as a Scientific Director. Hazel has eight years’ experience in medical communications with particular expertise in the fields of neurology, immunology and rheumatology.

  • Bringing the NHS into the 21st century

    We have consultants specialising in cardiology, endocrine, ENT, gynaecology, haematology, neurology, respiratory, orthopaedics, rheumatology, and urology.

  • Healthcircle

    Rx &Medical Devices. Oncology. Haematology. Rheumatology. Anti-infectives. Anti-virals. Cardiovascular. Respiratory. Endocrinology.


    Our diverse experience in human and animal health includes:. gastroenterology . rheumatology .

  • The Biosimilar Challenge

    In fact, recent self-funded work, showed that 89% of UK payers now positively endorse the use of biosimilars across a range of therapy areas – especially in rheumatology. ... The pressure is now on to undertake the same in rheumatology, dermatology and

More from PMHub
Approximately 2 fully matching, plus 18 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....